Device/Diagnostics Quarterly Deal Statistics, Q4 2012

A look at financing, M&A, and alliance activity, October – December 2012

Device firms closed the final quarter of 2012 with $1.1 billion in financing, led by Volcano’s debt offering. Takeovers of Gambro and PSS Medical topped the device M&A list. At $196 million, Q4 diagnostic financing was the lowest quarter of the year, but IPOs returned with three public debuts. Amgen’s $415 million acquisition of deCODE was the largest diagnostic M&A.

Device companies finished off 2012 raising $1.1 billion in the fourth quarter (a 40% increase over Q3’s $801 million), capping off the year with a grand total of $4 billion in funding, falling just a hair short of the $4.1 billion that was amassed in 2011. Similar to last year, there was a strong showing from debt and late-stage venture capital financings across all four quarters. (See Exhibit 1.)

Click here

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Deal-Making

More from In Vivo